LATOSHA MACKEY: Open Payments
NPI 1861038747 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$692 in 39 payments from 11 companies in 2025. Trend: 2023 $553 · 2024 $609 · 2025 $692
Food & beverage: $692
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $192 |
| Novo Nordisk Inc | 6 | $112 |
| Exact Sciences Corporation | 3 | $73 |
| ABBVIE INC. | 4 | $63 |
| Phathom Pharmaceuticals, Inc. | 7 | $58 |
| Lilly USA, LLC | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Ardelyx, Inc. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Biogen, Inc. | 1 | $18 |
Products named: BREZTRI, FARXIGA, JARDIANCE, VOQUEZNA, AIRSUPRA, Ozempic, CAPLYTA, The Cologuard Plus Collection Kit.
Industry payments across LA — which companies pay providers there.
